{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:26:52Z","timestamp":1784366812979,"version":"3.55.0"},"reference-count":69,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Chronic kidney disease (CKD) has been a constant burden worldwide, with a prevalence of more than 10% of the population and with mortality reaching 1.2 million deaths and 35.8 million disability-adjusted life years (DALYs) in 2017, as it is claimed by the Global Burden of Diseases. Moreover, an increase in its prevalence is expected in the next years due to a rise in the number of people suffering from obesity, diabetes mellitus and hypertension. On the other hand, with cardiovascular morbidity and mortality showing a downward trend, maybe it is time to focus on CKD, to minimize the preventable risk factors involved in its progression toward end-stage kidney disease (ESKD) and to offer a better quality of life. Another major health burden is represented by infectious diseases, particularly urinary tract infections (UTIs), as it is considered that approximately 40\u201350% of women and 5% of men will have at least one episode during their lifetime. Additionally, CKD consists of a constellation of immunological and metabolical disturbances that lead to a greater risk of UTIs: increased apoptosis of lymphocytes, elevated levels of tumor necrosis factor \u03b1 and interleukin 6, which lower the function of neutrophils and increased levels of uremic toxins like p-cresyl sulfate and indoxyl sulfate, which alter the adherence and migration of leukocytes to the sites of injury. Moreover, UTIs can lead to a more rapid decline of kidney function, especially in stages G3-G5 of CKD, with all the complications involved. Last, but not least, antibiotherapy is often complicated in this category of patients, as antibiotics can also negatively affect the kidneys. This review will try to focus on the particularities of the urinary microbiome, asymptomatic bacteriuria and UTIs and the subtle balance between the risks of them and the risks of antibiotherapy in the evolution of CKD.<\/jats:p>","DOI":"10.3390\/medicina59010049","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T04:58:01Z","timestamp":1672117081000},"page":"49","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Chronic Kidney Disease, Urinary Tract Infections and Antibiotic Nephrotoxicity: Are There Any Relationships?"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-5803","authenticated-orcid":false,"given":"Ioana","family":"Dicu-Andreescu","sequence":"first","affiliation":[{"name":"Clinical Department No 3, Internal Medicine and Nephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"\u201cDr. Carol Davila\u201d Teaching Hospital of Nephrology, Nephrology Department, Cal. Grivitei No 4, Sector 1, 010731 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea Niculae","family":"Penescu","sequence":"additional","affiliation":[{"name":"Clinical Department No 3, Internal Medicine and Nephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"\u201cDr. Carol Davila\u201d Teaching Hospital of Nephrology, Nephrology Department, Cal. Grivitei No 4, Sector 1, 010731 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"C\u0103pu\u0219\u0103","sequence":"additional","affiliation":[{"name":"Clinical Department No 3, Internal Medicine and Nephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"\u201cDr. Carol Davila\u201d Teaching Hospital of Nephrology, Nephrology Department, Cal. Grivitei No 4, Sector 1, 010731 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Verzan","sequence":"additional","affiliation":[{"name":"Clinical Department No 3, Internal Medicine and Nephrology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"\u201cDr. Carol Davila\u201d Teaching Hospital of Nephrology, Nephrology Department, Cal. Grivitei No 4, Sector 1, 010731 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: An update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int. Suppl."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2012.64","article-title":"Chapter 1: Definition and classification of CKD","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"19460","DOI":"10.1038\/s41598-020-76520-5","article-title":"Pyuria, urinary tract infection and renal outcome in patients with chronic kidney disease stage 3\u20135","volume":"10","author":"Kuo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10157-018-1641-8","article-title":"Clinical epidemiology of infectious disease among patients with chronic kidney disease","volume":"23","author":"Ishigami","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_5","unstructured":"Hooton, T., and Gupta, K. (2021). Uptodate\u2014Acute Simple Cystitis in Women, UpToDate Inc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/aje\/kwz246","article-title":"Inflammatory Markers and Incidence of Hospitalization with Infection in Chronic Kidney Disease","volume":"189","author":"Ishigami","year":"2020","journal-title":"Am. J. Epidemiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-111-11-906","article-title":"Urinary Tract Infections in Women: Diagnosis and Treatment","volume":"111","author":"Johnson","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1093\/cid\/ciz021","article-title":"Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa","volume":"68","author":"Nicolle","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hwang, J.H., Park, H.C., Jeong, J.C., Baek, S.H., Han, M.Y., Bang, K., Cho, J.Y., Yu, S.H., Yang, J., and Oh, K.-H. (2013). Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ki.1996.111","article-title":"Risk of developing end-stage renal disease in a cohort of mass screening","volume":"49","author":"Iseki","year":"1996","journal-title":"Kidney Int."},{"key":"ref_11","first-page":"Doc07","article-title":"Urinary tract infections in patients with renal insufficiency and dialy-sis\u2014Epidemiology, pathogenesis, clinical symptoms, diagnosis and treatment","volume":"9","author":"Scherberich","year":"2021","journal-title":"GMS Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/QCO.0000000000000127","article-title":"Innate immunity and genetic determinants of urinary tract infection susceptibility","volume":"28","author":"Godaly","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_13","first-page":"404","article-title":"The role of toll-like receptors (TLRs) in urinary tract infections (UTIs)","volume":"69","author":"Behzadi","year":"2016","journal-title":"Central Eur. J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41585-021-00477-x","article-title":"Molecular determinants of disease severity in urinary tract infection","volume":"18","author":"Ambite","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrneph.2010.16","article-title":"The role of Toll-like receptors in renal diseases","volume":"6","author":"Banach","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hawn, T.R., Scholes, D., Li, S.S., Wang, H., Yang, Y., Roberts, P.L., Stapleton, A., Janer, M., Aderem, A., and Stamm, W.E. (2009). Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005990"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"931717","DOI":"10.3389\/fmed.2022.931717","article-title":"A Systematic Review of the (Un)known Host Immune Response Biomarkers for Predicting Recurrence of Urinary Tract Infection","volume":"9","author":"Hosman","year":"2022","journal-title":"Front. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5114\/ceji.2022.119625","article-title":"Toll-like receptor (TLR2, TLR4) polymorphisms and their influence on the incidence of urinary tract infections in children with and without urinary tract malformation","volume":"47","author":"Krakowska","year":"2022","journal-title":"Central Eur. J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.4049\/jimmunol.178.8.4717","article-title":"Cutting Edge:Tlr5\u2212\/\u2212Mice Are More Susceptible to Escherichia coli Urinary Tract Infection","volume":"178","author":"Hawn","year":"2007","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.chom.2012.04.016","article-title":"Toll-like Receptor 7 Is Required for Effective Adaptive Immune Responses that Prevent Persistent Virus Infection","volume":"11","author":"Walsh","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/ndt\/gfp532","article-title":"Functional polymorphisms in transforming growth factor-beta-1 (TGF -1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection","volume":"25","author":"Hussein","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmhg.2014.02.003","article-title":"The promoter region (G-800A and C-509T) polymorphisms of transforming growth factor-\u03b21 gene among young women with recurrent urinary tract infection","volume":"15","author":"Syukri","year":"2014","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/apa.13897","article-title":"Vascular endothelial growth factor-A gene polymorphism is associated with congenital renal lesions in children with urinary tract infections","volume":"106","author":"Bimpaki","year":"2017","journal-title":"Acta Paediatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/322030","article-title":"CXC Chemokine Receptor 2 Contributes to Host Defense in Murine Urinary Tract Infection","volume":"184","author":"Olszyna","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/nep.13260","article-title":"Association between interleukin 8-receptor gene (CXCR1 and CXCR2) polymorphisms and urinary tract infection: Evidence from 4097 subjects","volume":"24","author":"Han","year":"2019","journal-title":"Nephrology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2362.2008.02004.x","article-title":"TLR- and CXCR1-dependent innate immunity: Insights into the genetics of urinary tract infections","volume":"38","author":"Fischer","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.gene.2017.10.060","article-title":"Testing an association between TLR4 and CXCR1 gene polymorphisms with susceptibility to urinary tract infection in type 2 diabetes in north Indian population","volume":"641","author":"Gond","year":"2018","journal-title":"Gene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1128\/CDLI.12.12.1358-1363.2005","article-title":"Expression of Interleukin-8 Receptors (CXCR1 and CXCR2) in Premenopausal Women with Recurrent Urinary Tract Infections","volume":"12","author":"Smithson","year":"2005","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_29","first-page":"e12486","article-title":"Urinary Tract Infection in Chronic Kidney Disease Population: A Clinical Observational Study","volume":"13","author":"Shankar","year":"2021","journal-title":"Cureus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"617002","DOI":"10.3389\/fcimb.2021.617002","article-title":"Urinary Microbiome: Yin and Yang of the Urinary Tract","volume":"11","author":"Soriano","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrurol.2014.361","article-title":"The microbiome of the urinary tract\u2014A role beyond infection","volume":"12","author":"Whiteside","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejogrb.2018.06.011","article-title":"Age, menopausal status and the bladder microbiome","volume":"228","author":"Curtiss","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/ajt.14038","article-title":"Changes in Urinary Microbiome Populations Correlate in Kidney Transplants with Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies","volume":"17","author":"Modena","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.3389\/fmed.2021.790783","article-title":"The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword","volume":"8","author":"Wehedy","year":"2022","journal-title":"Front. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MOU.0000000000000367","article-title":"Clinical implications of the microbiome in urinary tract diseases","volume":"27","author":"Hiergeist","year":"2017","journal-title":"Curr. Opin. Urol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0090-4295(77)90004-8","article-title":"Urinalysis in patients on chronic hemodialysis","volume":"10","author":"Cabaluna","year":"1977","journal-title":"Urology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3343\/alm.2020.40.3.238","article-title":"Prevalence and Clinical Characteristics of Asymptomatic Pyuria in Chronic Kidney Disease","volume":"40","author":"Kwon","year":"2020","journal-title":"Ann. Lab. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14414","DOI":"10.1038\/s41598-021-93912-3","article-title":"Risk factors for urosepsis in chronic kidney disease patients with urinary tract infections","volume":"11","author":"Dimitrijevic","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tocut, M., Zohar, I., Schwartz, O., Yossepowitch, O., and Maor, Y. (2022). Short- and long-term mortality in patients with urosepsis caused by Escherichia coli susceptible and resistant to 3rd generation cephalosporins. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07538-5"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.ackd.2019.08.001","article-title":"Nephrotoxicity of Antimicrobials and Antibiotics","volume":"27","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1179\/joc.2001.13.5.461","article-title":"Renal Transport of Antibiotics and Nephrotoxicity: A Review","volume":"13","author":"Fanos","year":"2001","journal-title":"J. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"13372","DOI":"10.1038\/s41598-018-31612-1","article-title":"Association of Kidney Function with Infections by Multidrug-Resistant Organisms: An Electronic Medical Record Analysis","volume":"8","author":"Su","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2013.09.009","article-title":"Dosing Errors in Prescribed Antibiotics for Older Persons With CKD: A Retrospective Time Series Analysis","volume":"63","author":"Farag","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e2224892","DOI":"10.1001\/jamanetworkopen.2022.24892","article-title":"Association of Higher-Dose Fluoroquinolone Therapy with Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease","volume":"5","author":"Muanda","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10096-017-2911-1","article-title":"Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: Antibiotic stewardship implications","volume":"36","author":"Cunha","year":"2017","journal-title":"Eur. J. Clin. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1345\/aph.1R352","article-title":"Nitrofurantoin Contraindication in Patients with a Creatinine Clearance Below 60 mL\/min: Looking for the Evidence","volume":"47","author":"Oplinger","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Golightly, L.K., Teitelbaum, I., Simendinger, B.A., Kiser, T.H., Barber, G.R., and Stolpman, N.M. (2021). Renal Pharmacotherapy. Dosage Adjustment of Medications Eliminated by the Kidneys, Springer.","DOI":"10.1007\/978-3-030-58650-8"},{"key":"ref_49","unstructured":"(2022, November 17). Uptodate\u2014Fosfomycin: Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/fosfomycin-drug-information."},{"key":"ref_50","unstructured":"Uptodate (2022, November 17). Amoxicillin and Clavulanate: Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/amoxicillin-and-clavulanate-drug-information."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.34067\/KID.0000042019","article-title":"Management of Drug-Associated Acute Interstitial Nephritis","volume":"1","author":"Barreto","year":"2020","journal-title":"Kidney360"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Uptodate (2022, November 17). Cefpodoxime: Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/cefpodoxime-drug-information.","DOI":"10.1097\/01.NPR.0000873556.24995.ba"},{"key":"ref_53","unstructured":"Uptodate (2022, November 17). Cefdinir: Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/cefdinir-drug-information."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2215\/CJN.10710918","article-title":"Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD","volume":"14","author":"Bathini","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Uptodate (2022, November 17). Cefadroxil: Drug information. Available online: https:\/\/www.uptodate.com\/contents\/cefadroxil-drug-information.","DOI":"10.1097\/01.NPR.0000873556.24995.ba"},{"key":"ref_56","unstructured":"Uptodate (2022, November 17). Cephalexin: Drug information. Available online: https:\/\/www.uptodate.com\/contents\/cephalexin-drug-information."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Uptodate (2022, November 17). Ceftriaxone: Drug information. Available online: https:\/\/www.uptodate.com\/contents\/ceftriaxone-drug-information.","DOI":"10.1097\/01.NPR.0000873556.24995.ba"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"E475","DOI":"10.1503\/cmaj.121730","article-title":"Risk of acute kidney injury associated with the use of fluoroquinolones","volume":"185","author":"Bird","year":"2013","journal-title":"Can. Med. Assoc. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40800-018-0073-4","article-title":"Nephrotoxicity of Ciprofloxacin: Five Cases and a Review of the Literature","volume":"5","author":"Hajji","year":"2018","journal-title":"Drug Saf.-Case Rep."},{"key":"ref_60","first-page":"29","article-title":"Crystal-induced acute kidney injury due to ciprofloxacin","volume":"4","author":"Khan","year":"2015","journal-title":"J. Nephropathol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Uptodate (2022, November 17). Ciprofloxacine (Systemic): Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/ciprofloxacin-systemic-drug-information.","DOI":"10.1097\/01.NPR.0000873556.24995.ba"},{"key":"ref_62","unstructured":"Uptodate (2022, November 17). Levofloxacin (Systemic): Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/levofloxacin-systemic-drug-information."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamacardio.2021.4234","article-title":"Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis","volume":"7","author":"Assimon","year":"2022","journal-title":"JAMA Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The Nephrotoxicity of Vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_65","first-page":"57","article-title":"Drug-induced renal disorders","volume":"4","author":"Shahrbaf","year":"2015","journal-title":"J. Ren. Inj. Prev."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Uptodate (2022, November 17). Vancomycin: Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/vancomycin-drug-information.","DOI":"10.1097\/01.NPR.0000873556.24995.ba"},{"key":"ref_67","unstructured":"Uptodate (2022, November 17). Piperacillin and Tazobactam: Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/piperacillin-and-tazobactam-drug-information."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s15010-020-01480-x","article-title":"Evaluation of the risk of acute kidney injury with the use of piperacillin\/tazobactam among adult critically ill patients","volume":"48","author":"Saad","year":"2020","journal-title":"Infection"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1681\/ASN.2018121223","article-title":"Piperacillin\/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children","volume":"30","author":"Joyce","year":"2019","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/49\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:52:24Z","timestamp":1760147544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/1\/49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["medicina59010049"],"URL":"https:\/\/doi.org\/10.3390\/medicina59010049","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]}}}